| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.092 | 0.008 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.009 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.15 | 0.009 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.15 | 0.01 |